A New York judge has cleared the way for litigation to continue over an alleged breach in a $275 million loan to a rare pharmaceutical manufacturer subsequently acquired by Biogen, Inc.

Acting Manhattan Supreme Court Justice Anar Rathod Patel last week denied a motion to dismiss from defendants Reata and Biogen, finding that fact questions remained.